Brief: Galenica H1 Consolidated Net Sales At CHF 1.85 Bln

Galenica AG

08/08/2023 05:45

Aug 8 (Reuters) - GALENICA AG  GALE.S :
    * IN THE FIRST HALF OF 2023, GALENICA INCREASED CONSOLIDATED
NET
SALES BY 5.5% COMPARED TO THE FIRST HALF OF THE PREVIOUS YEAR TO
CHF 1,851.2 MILLION
    * COMPLETION OF THE STRATEGIC PARTNERSHIP AND JOINT VENTURE
WITH
REDCARE PHARMACY (FORMERLY SHOP APOTHEKE EUROPE) RESULTED IN A
PROFIT OF CHF 112.8 MILLION (PROFIT FROM DISCONTINUED
OPERATIONS)
    * H1 NET PROFIT INCREASED TO CHF 187.3 MILLION (PREVIOUS
YEAR: CHF
83.1 MILLION)
    * OUTLOOK 2023: EXPECTS ADJUSTED² EBIT TO BE ROUGHLY AT THE
PRIOR-YEAR LEVEL BASED ON THE RESTATED1 PRIOR-YEAR FIGURES
(ADJUSTED² EBIT 2022: CHF 190.6 MILLION)
    * ON THE OTHER HAND, GALENICA CONFIRMS ITS 2023 OUTLOOK FOR
CONSOLIDATED NET SALES (GROWTH BETWEEN 3% AND 6%) AND DIVIDENDS
(AT LEAST AT THE SAME LEVEL AS THE PREVIOUS YEAR)

Further company coverage:  GALE.S 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))